BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 1346164)

  • 1. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide and the kidney.
    Ballermann BJ; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):7-12. PubMed ID: 3037892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of atrial natriuretic peptide infusion in young and adult rats.
    Chevalier RL; Gomez RA; Carey RM; Peach MJ; Linden JM
    Pediatr Res; 1988 Sep; 24(3):333-7. PubMed ID: 2850523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
    Pesonen A; Leppäluoto J; Ruskoaho H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of atrial natriuretic peptide on sodium homeostasis in experimental renal failure.
    Nitta K; Naruse M; Sanaka T; Tsuchiya K; Sugino N
    Jpn J Exp Med; 1989 Oct; 59(5):181-8. PubMed ID: 2533287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic factor after heart operations in children. Relation to hemodynamic and renal parameters.
    Girardin EP; Berner ME; Favre HR; Oberhaensli I; Rouge JC; Friedli B; Paunier L
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):526-31. PubMed ID: 1833593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
    Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives.
    Wilkins MR; Lewis HM; West MJ; Kendall MJ; Lote CJ
    J Hum Hypertens; 1987 Jun; 1(1):47-51. PubMed ID: 2977404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between plasma atrial natriuretic peptide (ANP) and glomerular ANP receptors in 5/6 nephrectomized rats.
    Jin H; Yuan ZY; Du XH; Su G; Zhang L; Wang MX; Dong Y; Liu DX; Zou WZ; Wang SL
    Chin Med J (Engl); 1990 Oct; 103(10):794-9. PubMed ID: 2176581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
    Ma J; Peng A; Lin S
    Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
    López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J
    Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a ring-deleted atrial natriuretic factor analogue on ovine fetal renal and cardiovascular function.
    Castro R; Ervin MG; Leake RD; Ross MG; Fisher DA
    Pediatr Res; 1991 Apr; 29(4 Pt 1):342-6. PubMed ID: 1649430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of atrial natriuretic peptide in cirrhotic rats with and without captopril pretreatment.
    Brunkhorst R; Wrenger E; Malcharzik C; Brabant G; Koch KM
    Nephron; 1993; 64(2):275-81. PubMed ID: 8321362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
    Caron N; Kramp R
    Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.